MaxCyte, Inc. logo

MaxCyte, Inc.

NASDAQ:MXCT

Overview | Financials
Company Name MaxCyte, Inc.
Symbol MXCT
Currency USD
Price 3.86
Market Cap 405,644,351
Dividend Yield 0%
52-week-range 3.15 - 5.545
Industry Medical Devices
Sector Healthcare
CEO Mr. Douglas Arthur Doerfler
Website https://maxcyte.com

An error occurred while fetching data.

About MaxCyte, Inc.

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic

Related Stocks

Nurix Therapeutics, Inc. logo

Nurix Therapeutics, Inc.

NRIX

25.43 USD

OptimizeRx Corporation logo

OptimizeRx Corporation

OPRX

5.11 USD

Janux Therapeutics, Inc. logo

Janux Therapeutics, Inc.

JANX

55.28 USD

Seer, Inc. logo

Seer, Inc.

SEER

2.03 USD

Ocugen, Inc. logo

Ocugen, Inc.

OCGN

0.95 USD

AirSculpt Technologies, Inc. logo

AirSculpt Technologies, Inc.

AIRS

6.79 USD

PetMed Express, Inc. logo

PetMed Express, Inc.

PETS

4.265 USD

Immunovant, Inc. logo

Immunovant, Inc.

IMVT

30.32 USD

Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc.

ATRA

10.28 USD

Financials

Numbers are in millions USD

Numbers are in millions USD